Fungemia

Search with Google Search with Bing
Information
Disease name
Fungemia
Disease ID
Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT00001810 Completed Phase 3 An Open Label, Non-Comparative, Multicenter, Phase III Trial of the Efficacy, Safety and Toleration of Voriconazole in the Primary or Secondary Treatment of Invasive Fungal Infections April 1999 October 2000
NCT00001937 Completed Phase 3 Comparing the Effectiveness of Fluconazole and a New Medicine (FK463) in Preventing Fungal Infections in Bone Marrow Transplant Patients November 1999 December 2000
NCT00027248 Completed Phase 3 Safety and Efficacy of MBI 226 for the Prevention of Central Venous Catheter-Related Bloodstream Infections September 2000 July 2003
NCT00177788 Completed Voriconazole as Prophylaxis for Liver Transplant Recipients September 2005 August 2012
NCT01359891 Completed Clinical Evaluation of Novel Biomarkers in Patients With Septicemia November 2010 August 2021
NCT01450358 Completed Phase 4 Evaluation in the Treatment of Nosocomial Sepsis Comparing Polymerase Chain Reaction With Conventional Blood Culture. January 2012 May 2016
NCT01898208 Completed N/A Rapid Identification and Susceptibility Testing of Pathogens From Blood Cultures August 2013 August 2014
NCT02719769 Completed Clinical Performance of the Accelerate ID/AST System for Positive Blood Culture January 2016 January 12, 2017
NCT02734862 Completed Phase 2 CD101 Compared to Caspofungin Followed by Oral Step Down in Subjects With Candidemia and/or Invasive Candidiasis-Bridging Extension July 26, 2016 July 2019
NCT03876990 Completed N/A Clinical and Medico-economic Evaluation of a Rapid Test (ePlex-BCID®, GenMark) for the Diagnosis of Bacteremia and Fungemia. June 20, 2019 February 19, 2021
NCT00794703 Completed Phase 3 A Study to Compare Efficacy and Safety of Mycamine® and Itraconazole for Preventing Fungal Infections November 2008 November 2009
NCT00841971 Completed Phase 4 Anidulafungin Versus Fluconazole for the Prevention of Fungal Infections in Liver Transplant Recipients February 2010 May 2014
NCT01236261 Completed Prospective Population Study on Candidemia in Spain March 2013 March 2013
NCT04368559 Recruiting Phase 3 Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow Transplantation May 11, 2020 August 2024
NCT00805740 Terminated Phase 3 An Evaluation Of The Effectiveness And Safety Of Anidulafungin Compared To Caspofungin For The Treatment Of Deep Tissue Infection Due To Candida April 2009 June 2012
NCT00806351 Terminated Phase 3 An Evaluation Of The Effectiveness And Safety Of Anidulafungin Compared To Caspofungin For The Treatment Of Serious Fungal Infection Due To Candida In Patients With A Dysfunctional Immune System August 2009 October 2011
NCT00460330 Unknown status Evaluate Three Methods for Diagnosis of Invasive Fungal Infection in Chinese Patients After HSCT April 2007 December 2008
NCT01260974 Unknown status Phase 2 Caspofungin as Prophylaxis in High Risk Liver Transplantation Recipients May 2009 November 2012
NCT02743585 Unknown status N/A Impact of Rapid Pathogen Identification From Blood Cultures (RABbIT) March 20, 2017 July 2, 2020
MedGen concept unique identifier (MedGen Concept name)
C0085082
MedGen unique identifier (MedGen Concept name)
88323
MeSH unique ID (MeSH (Medical Subject Headings))
D016469